Acceder

Publicaciones - INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA

Cargando...
Muro M, Legaz I. Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation. World J Gastroenterol. 2023 Feb 7;29(5):766-772. doi: 10.3748/wjg.v29.i5.766. PubMed PMID: 36816626; PubMed Central PMCID: PMC9932425.
AÑO: 2023; IF: 4.3
36816626
Morales R, Bolarin JM, Muro M, Legaz I. Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure. Diagnostics (Basel). 2023 Mar 23;13(7):1217. doi: 10.3390/diagnostics13071217. PubMed PMID: 37046435; PubMed Central PMCID: PMC10093628.
AÑO: 2023; IF: 3.0
37046435
Boix F, Jimenez-Coll V, Legaz I, Alfaro R, Moya-Quiles MR, Pena-Moral J, Minguela A, Llorente S, Muro M. Higher Expression of Activated CD8+ T Lymphocytes (CD8+CD25+, CD8+CD69+ and CD8+CD95+) Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients. Front Biosci (Landmark Ed). 2023 Jun 27;28(6):119. doi: 10.31083/j.fbl2806119. PubMed PMID: 37395036.
AÑO: 2023; IF: 3.3
37395036
Muro-Perez M, Gonzalez-Martinez G, Martinez-Garcia P, Legaz I, Zafrilla P, Muro M. Analysis of null deletion polymorphism of glutathione S-transferase theta (GSTT-1), associated with anti-GSTT-1 antibodies development in transplantation. Int J Immunogenet. 2023 Oct;50(5):264-271. doi: 10.1111/iji.12635. Epub 2023 Aug 23. PubMed PMID: 37612787.
AÑO: 2023; IF: 2.3
37612787
Podzamczer D, Imaz A, Lopez-Lirola A, Knobel H, Masia M, Fanciulli C, Hernandez C, Lagarde M, Gutierrez A, Curran A, Morano L, Montero-Alonso M, Troya J, Rigo R, Casadella M, Navarro-Alcaraz A, Ardila F, Parera M, Bernal E, Echeverria P, Estrada V, Hidalgo-Tenorio C, Macias J, Prieto P, Portilla J, Valencia E, Vivancos MJ, Rivero A. Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens. J Antimicrob Chemother. 2023 Nov 6;78(11):2696-2701. doi: 10.1093/jac/dkad285. PubMed PMID: 37725999.
AÑO: 2023; IF: 3.9
37725999
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA